Dr. Ramkissoon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
75 Francis St
Brigham And Womens Hospital, Dept Of Pathology
Boston, MA 02115Phone+1 617-732-7510
Education & Training
Brigham and Women's HospitalFellowship, Neuropathology, 2009 - 2011- Brigham and Women's HospitalResidency, Pathology-Anatomic and Clinical, 2007 - 2009
Rutgers New Jersey Medical SchoolClass of 2007
Certifications & Licensure
CA State Medical License 2021 - 2027
NY State Medical License 2023 - 2026
MA State Medical License 2010 - 2025
MD State Medical License 2023 - 2025
NC State Medical License 2016 - 2025
American Board of Pathology Pathology - Anatomic- American Board of Pathology Neuropathology
Publications & Presentations
PubMed
- Analytical Validation of the Labcorp Plasma Complete Test, a Cell-Free DNA Comprehensive Genomic Profiling Tool for Precision Oncology.Ellen L Verner, Jennifer B Jackson, Cynthia Maddox, Kenneth C Valkenburg, James R White
The Journal of Molecular Diagnostics. 2025-03-01 - Current laboratory testing practices for mismatch repair deficiency and microsatellite instability testing: A survey-based review of current laboratory practices.Amy L Austin, Russell R Broaddus, Rhona J Souers, Megan E Kane, Ravindra Kolhe
American Journal of Clinical Pathology. 2025-01-28 - Analysis of real world FRα testing in ovarian, fallopian tube, and primary peritoneal cancers.Rebecca A Previs, Kyle C Strickland, Zachary Wallen, Heidi Ko, Michelle Green
Gynecologic Oncology. 2025-01-01
Journal Articles
- Institutional Implementation of Clinical Tumor Profiling on an Unselected Cancer PopulationKhanh Do, Lauren L Ritterhouse, William C Hahn, Geoffrey I Shapiro, Barrett J Rollins, Neal I Lindeman, Alanna Church, Geoffrey R Oxnard, Bruce E Johnson, Frank C Kuo,..., The Journal of Clinical Investigation
Abstracts/Posters
- Loss of Heterozygosity of FLT3-ITD Is Common in Acute Myeloid Leukemia and May be a More Consistent Prognostic Marker Than FLT3-ITD Allele FrequencyShakti H. Ramkissoon, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Acid-Based Decalcification Methods Compromise Genomic Profiling from DNA and RNAShakti H. Ramkissoon, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Press Mentions
Labcorp Announces Clinical Availability of Liquid Biopsy Test to Guide Personalized Treatment Plans for Patients with Advanced Solid TumorsFebruary 25th, 2025- Labcorp Announces Clinical Availability of Liquid Biopsy Test to Guide Personalized Treatment Plans for Patients with Advanced Solid TumorsFebruary 24th, 2025
- RNA Sequencing Critical to Identifying Key Fusions for Oncology PatientsNovember 8th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
